Flamiar Spag Peca ointment 35 g. tube

$24.00

Manufacturer: Germany

Purpose: Treats fungal infections on skin by targeting and killing fungi.

SKU: MED58475 Category:

Description

Flamiar Spag Peca Ointment 35 g Tube

Ingredients

Flamiar Spag Peca Ointment contains active ingredients such as [insert active ingredients], along with other inactive ingredients.

Mechanism of Action

Pharmacological Properties: Flamiar Spag Peca Ointment exerts its effects by [describe the mechanism of action, how it interacts with the body, etc.].

Indications for Use

Indications: Flamiar Spag Peca Ointment is indicated for the relief of [insert indications].

Contraindications

Contraindications: Do not use Flamiar Spag Peca Ointment if you are allergic to any of the ingredients.

Side Effects

Side Effects: Common side effects may include [list common side effects, if any]. Consult your healthcare provider for more information.

Usage Instructions

Dosage and Administration: For adults and children, apply a thin layer of the ointment to the affected area 2-3 times a day or as directed by a healthcare professional.

Directions: Clean and dry the affected area before applying the ointment. Wash your hands after application.

Benefits Compared to Analogues

Benefits: Flamiar Spag Peca Ointment offers [mention specific benefits or advantages compared to similar products in the market].

Suitable Patient Groups

Patient Groups: This ointment is suitable for [mention suitable patient groups such as children, elderly, etc.].

Storage and Shelf Life

  • Storage: Store the ointment at room temperature away from moisture and heat.
  • Shelf Life: Check the expiration date on the packaging and do not use the product beyond that date.

Packaging Description

Packaging: The ointment is available in a 35 g tube for easy application and storage.

Clinical Evidence and Proven Effectiveness

Clinical Trials: Clinical trials have demonstrated the efficacy of Flamiar Spag Peca Ointment in [mention specific conditions or outcomes tested in clinical trials].